Esperion Therapeutics Cash Flow - Annual (NASDAQ:ESPR)

Add to My Stocks
$38.27 $0.67 (1.72%) ESPR stock closing price Mar 27, 2017 (Closing)
Annual
Quarterly
View Previous Years
View Next Years
Fiscal year is Jan - Dec. 2016 2015 2014 2013 2012 2011
Esperion Therapeutics Net Income Cash Flow
-74.97M-49.78M-36.37M-26.08M-11.74M-10.81M
Depreciation Depletion Amortization Cash-Flow1.31M0.94M0.39M0.59M0.27M0.17M
Net Increase (Decrease) in Assets Liabilities9.98M-2.08M0.25M3.22M-0.84M0.8M
Cash From (used in) Discontinued Operations------
Other Adjustments Net15.95M12.77M3.71M4.15M0.04M0.08M
Esperion Therapeutics Net Cash from (used by) Operating Activities
-47.73M-38.15M-32.02M-18.11M-10.8M-9.06M
Increase (Decrease) in Prop Plant And Equipment-0.09M-0.3M-0.86M0.16M-0.01M
Acquisition Disposition of Subsidiaires------
Increase (Decrease) in Investments10.21M-159.76M-35.73M-21.17M-0.5M
Other Cash Inflow (Outflow) from Investment Activities------
Esperion Therapeutics Net Cash from (used by) Invesment Activities
10.11M-160.06M-36.59M-21M-0.5M
Issuance (Purchase) of Equity Shares0.04M191.16M92.28M89.14M0.04M6.71M
Issuance (Repayment) of Debt Securities-1.6M-0.63M4.83M-15.41M-
Increase (Decrease) in Bank & Other Borrowings------
Payment of Dividends & Other Cash Distributions------
Other Cash from (used by) Financing Activities
Esperion Therapeutics Net Cash from (used by) Financing Activities
-1.55M190.52M97.12M89.14M15.75M6.71M
Effect of Exchange Rate Changes on Cash------
Esperion Therapeutics Net Change in Cash & Cash Equivalents
-39.17M-7.7M28.5M50.02M4.94M-1.84M
Cash & Equivalents at Beginning of Year77.33M85.03M56.53M6.51M1.57M3.41M
Cash & Equivalents at Year End38.16M77.33M85.03M56.53M6.51M1.57M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Cash flow for another ticker